CINECA IRIS Institutional Research Information System

ROMAGNOLO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.844
AS - Asia 3.352
EU - Europa 2.883
SA - Sud America 533
AF - Africa 79
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.681
SG - Singapore 1.290
CN - Cina 879
IT - Italia 758
BR - Brasile 407
VN - Vietnam 374
DE - Germania 334
IE - Irlanda 280
SE - Svezia 270
FR - Francia 268
FI - Finlandia 198
GB - Regno Unito 149
HK - Hong Kong 141
AT - Austria 139
JP - Giappone 139
IN - India 128
CA - Canada 98
KR - Corea 93
NL - Olanda 82
ES - Italia 73
BD - Bangladesh 62
AR - Argentina 60
PL - Polonia 52
TR - Turchia 47
UA - Ucraina 45
BE - Belgio 43
MX - Messico 39
AU - Australia 38
ID - Indonesia 34
IQ - Iraq 30
RU - Federazione Russa 27
PT - Portogallo 26
CH - Svizzera 22
ZA - Sudafrica 20
CO - Colombia 17
GR - Grecia 17
RO - Romania 17
CZ - Repubblica Ceca 16
EC - Ecuador 16
TW - Taiwan 16
MA - Marocco 15
UZ - Uzbekistan 13
CL - Cile 11
AE - Emirati Arabi Uniti 10
IR - Iran 10
PK - Pakistan 10
EG - Egitto 9
LT - Lituania 9
PH - Filippine 9
HR - Croazia 8
TH - Thailandia 8
BG - Bulgaria 7
OM - Oman 7
SI - Slovenia 7
SN - Senegal 7
TN - Tunisia 7
CY - Cipro 6
DK - Danimarca 6
RS - Serbia 6
SA - Arabia Saudita 6
UY - Uruguay 6
AL - Albania 5
CR - Costa Rica 5
KE - Kenya 5
MY - Malesia 5
PE - Perù 5
DZ - Algeria 4
GE - Georgia 4
JM - Giamaica 4
MD - Moldavia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
VE - Venezuela 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
SV - El Salvador 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
HN - Honduras 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MM - Myanmar 2
MT - Malta 2
NO - Norvegia 2
NP - Nepal 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 12.716
Salva come PNG Salva come JPEG
Città #
Singapore 751
Chandler 616
San Jose 584
Ashburn 482
Santa Clara 397
Beijing 363
Dublin 278
Dallas 202
Ann Arbor 191
Torino 188
Fairfield 172
Munich 144
Houston 127
Helsinki 122
Vienna 118
Nyköping 115
Hong Kong 100
Ho Chi Minh City 98
Lauterbourg 97
Los Angeles 96
Wilmington 94
Redwood City 91
Columbus 90
Turin 88
Woodbridge 88
Medford 87
Hanoi 85
Princeton 78
The Dalles 77
Villeurbanne 74
New York 69
Seoul 66
Seattle 62
Buffalo 58
Dearborn 58
Hefei 50
Cambridge 49
Milan 47
Boston 46
São Paulo 41
Jacksonville 39
Dong Ket 37
Tokyo 37
Warsaw 36
Amsterdam 35
Boardman 33
Hangzhou 31
Brussels 30
Shanghai 30
Collegno 28
Guangzhou 28
Pisa 28
Fremont 27
Rome 27
Turku 26
Frankfurt am Main 24
Madrid 24
Jakarta 23
Redondo Beach 23
Orem 22
Düsseldorf 20
Nanjing 19
Chengdu 18
London 18
Bengaluru 17
Da Nang 16
Montreal 15
Norwalk 15
Haiphong 14
Mumbai 14
Ottawa 14
Silver Spring 14
Toronto 14
Washington 14
Atlanta 13
Chicago 13
Hebei 13
Baghdad 12
Istanbul 12
Johannesburg 12
Nuremberg 12
Sydney 12
Xian 12
Brasília 11
Central District 11
Council Bluffs 11
Rio de Janeiro 11
Biên Hòa 10
Mexico City 10
Phoenix 10
Porto Alegre 10
Stockholm 10
Vancouver 10
Wuhan 10
Belo Horizonte 9
Bologna 9
Brooklyn 9
Buenos Aires 9
Falkenstein 9
Fort Worth 9
Totale 7.728
Salva come PNG Salva come JPEG
Nome #
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 761
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 523
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis 480
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 435
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. 349
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 282
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 276
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 237
Neurological comorbidity and severity of COVID-19 211
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 202
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 197
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 170
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 165
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 163
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 159
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 151
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 151
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 147
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 144
Advanced therapies in Parkinson's disease: Long-term retrospective study 141
CIDP-like neuropathies in graft versus host disease 134
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 133
A new index to assess turning quality and postural stability in patients with Parkinson's disease 132
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 131
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 131
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 130
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 130
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 129
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 126
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 125
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 124
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences 124
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 123
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 122
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 121
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 121
COVID-19 and Parkinson's Disease: What We Know So Far? 120
Autonomic dysfunction in Parkinson's disease: A prospective cohort study 119
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 119
COVID-19 in Parkinson's disease: Report on prevalence and outcome 119
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis. 118
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure? 117
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 116
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 116
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 113
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 113
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 112
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 111
Neurological comorbidities and COVID-19-related case fatality: A cohort study 110
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 109
Telemedicine in Neurological Disorders: Opportunities and Challenges 108
Home monitoring of motor fluctuations in Parkinson’s disease patients 107
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 106
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 106
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 104
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation 104
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 103
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 101
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 101
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 101
Transdermal rotigotine in dihydropteridine reductase deficiency 100
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data 99
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis 99
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 99
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit 97
Onset of Covid-19 with impaired consciousness and ataxia: a case report 97
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 96
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 95
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 95
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 95
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 95
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease 93
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study 92
Peripheral neuropathy as marker of severe Parkinson's disease phenotype 89
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 85
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 84
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 83
Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations 82
Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study 82
Preliminary evidence from a Line-Bisection Task for visuospatial neglect in Parkinson's disease 82
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 81
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 72
Prevalence and burden of dysautonomia in advanced Parkinson's disease 71
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis 71
Neurological symptoms in adults with Gaucher disease: a systematic review 70
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report 69
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 69
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 67
Functional neurological disorders in Parkinson disease 64
Levodopa-Induced Neuropathy: A Systematic Review 61
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 60
Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease 60
Expanded and independent validation of the NoMoFA scale for Parkinson's disease: the Italian version 58
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants 51
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?" 50
Theta-Gamma Subthalamic Stimulation for Verbal Fluency in Parkinson's Disease: A Randomized, Crossover Trial 47
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease 45
Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial 38
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease 28
The interplay between GBA1 status and age of onset on cognitive, motor and non-motor outcomes in Parkinson's disease: multicenter cross-sectional study 9
Totale 13.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.558
article - articoli 0
book - libri 0
conference - conferenze 726
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/20221.050 56 34 47 111 61 49 51 50 46 85 260 200
2022/20231.567 164 168 51 171 150 387 89 86 164 35 68 34
2023/2024751 110 128 42 26 76 96 26 46 4 57 41 99
2024/20252.296 31 105 62 192 579 204 136 162 237 125 175 288
2025/20264.243 516 205 383 473 476 211 637 166 320 546 251 59
Totale 13.014